Comparison

Vedolizumab European Partner

Item no. TMO-T9914-5mg
Manufacturer TargetMol
CASRN 943609-66-3
Amount 5 mg
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 943609-66-3
Shipping condition Cool pack
Available
Manufacturer - Targets
Integrin
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
147 kDa
Description
Vedolizumab, a humanized monoclonal antibody, targets the α4β7 integrin for treating Crohn's disease and ulcerative colitis.
Pathways
Cytoskeletal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Delivery expected until 1/31/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close